Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis iShares US Pharmaceuticals ETF IHE

The investment seeks to track the investment results of the Dow Jones U. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical... see more

Opinion & Analysis (ARCA:IHE)

    This Just Changed Everything: Green Profits Are Being Unleashed

    Streetwise Reports August 4, 2017

    Stock-moving catalysts anticipated for Regeneus in Q4/16

    The Life Sciences Report September 30, 2016

    Advanced Stem Cell Manufacture Saves Lives and Prints Money: Stewart Washer of Cynata Therapeutics

    The Life Sciences Report February 4, 2016

    A bucket of Canadian stocks set to soar in 2016

    The Life Sciences Report January 19, 2016

    Immunotherapy Inside the Cell: Three Companies on Their Way to the 'Holy Grail' of Cancer Treatment

    The Life Sciences Report January 6, 2016

    FDA Issues Long-Awaited Biological Product Naming convention

    Shreyas Deshmukh December 16, 2015

    ContraVir Pharmaceuticals brandishes a new weapon in biotech's antiviral wars

    Peter Byrne May 27, 2015

    February's Best And Worst ETFs

    Benzinga.com  March 3, 2015

    Apotex and the positive new world after the “Patent Cliff”

    Jerry Thomas December 1, 2014

    Drug ETFs Attractive Buys On Pullback

    Benzinga.com  October 22, 2014

    Johnson & Johnson, Goldman Sachs Pushing These ETFs Upward

    Benzinga.com  July 15, 2014

    ETF Outlook For Tuesday, April 29, 2014 (IHE, TAN, XRT, SOCL, TWTR)

    Benzinga.com  April 29, 2014

    3 Ways To Profit From Merger Activity In The Pharmaceutical Sector

    Benzinga.com  April 25, 2014

    Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga.com  April 22, 2014

    ETF Outlook For Tuesday, April 22, 2014 (PBS, IHE, IYT, EIRL, VRX, AGN, NFLX)

    Benzinga.com  April 22, 2014